McKesson Corporation vs Sirius XM Holdings Inc — how do they compare? McKesson Corporation trades at $938.84 (market cap $108.46B), while Sirius XM Holdings Inc trades at $26.51 (market cap $8.87B). The key difference: McKesson Corporation is far larger — about 12.2× Sirius XM Holdings Inc's market cap, and Sirius XM Holdings Inc pays the higher dividend (4.1%). Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Sirius XM Holdings Inc for 102 Days on average.
| MCK | SIRI | |
|---|---|---|
Market Cap | $108.46B | $8.87B |
Volume | 712,607 | 4,324,672 |
Sector | Health | Media |
52-Week High | $995.69 | $32.59 |
52-Week Low | $725.17 | $19.92 |
Typical Hold Time | 74 Days | 102 Days |
Enterprise Value | $115.00B | $18.16B |
Dividend Yield | 0.4% | 4.1% |
Signals from Pluang's Aura AI — not financial advice
McKesson (MCK) trades at $930.25, up 2.19% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $9.93 surpassing the $9.56 estimate. Revenue growth is robust, reaching $359.05B in 2025, though net margins are thin at 1.12%. Recent news highlights a key distribution extension with CVS Health through 2032, reinforcing long-term visibility.
The outlook is positive, driven by operational strength and strategic partnerships, but investors face risks from margin pressure and drug pricing uncertainty. With 81% of analysts rating it Buy and a consensus target of $956.43, the stock offers upside, though high RSI levels suggest near-term caution.
Sirius XM Holdings (SIRI) trades at $26.33, up 1.46% on the day, with a neutral technical signal and mixed earnings history. The stock shows attractive valuation metrics with a P/E of 10.57 and P/B of 0.75, while profitability remains solid with a 10.23% net margin. Recent news highlights the company's YouTube partnership potential and strong cash flow growth, with institutional buying activity noted in September 2026.
The outlook is cautiously optimistic with a consensus price target of $34.43 suggesting 31% upside, though risks include competitive pressures in audio streaming and execution on new initiatives. The company's debt reduction and stable cash generation support the bullish analyst sentiment, but investors should weigh the recent earnings misses against growth initiatives.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →